Skip to content

Author

Dongxuan Ni

We have 2 of 18 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Discovery of Diaryl Pyrimidine-Guanidine Derivatives as Jumonji C Domain-Containing Lysine Histone Demethylase (KDM) Inhibitors with In Vivo Anti-Cervical Cancer Activity

JMJD family histone demethylases are highly expressed in cervical cancer and promote tumor progression, highlighting their potential as therapeutic targets for this malignancy. Using a scaffold-hopping-based virtual screening, we discovered a series of diaryl pyrimidine-guanidine derivatives as KDM6B inhibitors. The...

Dong-Xuan Ni, Ting Wang, Ji-Jian Yang et al. · 0 citations
Open access Jul 2026

Design and synthesis of quinazoline derivatives as novel JMJD3/HDAC dual-target inhibitors.

A series of novel quinazoline derivatives designed and synthesized as potent dual inhibitors targeting histone lysine demethylase JMJD3 and histone deacetylases provide a novel scaffold for dual-target epigenetic drug discovery, a valuable chemical probe for investigating epigenetic crosstalk, and a promising candidate...

Li-Wei Wang, Yuke Zhang, Ke-Tong Chen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.